Will ADRO stock price go up or down on Tue, 28 May 2019?


Aduro Biotech Forecast and Stock Analysis

Technical ADRO stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-05-08 Loss -9.77%
Shorts n/a
Insider % n/a
Institutional % 56.90%
Beta 0.91
ROA -26.27%
Price to book USD 2.26
P/E Ratio -2.59
Next Earnings Date 2019-07-30

Aduro Biotech fell by -3.68% in the last day ( Thursday, 23rd May 2019 ) from $3.26 to $3.14 During day the stock fluctuated 7.82% from a day low at $3.07 to a day high of $3.31. The price has fallen in 7 of the last 10 days and is down by -5.99% for this period. Volume has increased in the last day by 117 581 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 427 351 shares bought and sold for approximately $1.34 million.

Quick summary:

  • 30 day high of the ADRO stock price was $4.59 and low was $2.82.
  • 90 day high was $4.59 and low was $2.82.
  • 52 week high for the Aduro Biotech - $9.00 and low - $2.34.


Aduro Biotech lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.88 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.73% during the next 3 months and, with 90% probability hold a price between $2.42 and $3.59 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Aduro Biotech holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.21 and $3.63. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday May 14, 2019, which indicates further falls until a new bottom pivot has been found. Aduro Biotech gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 26 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aduro Biotech finds support from accumulated volume at $3.13.

Support: $3.13 Price: $3.14 Resistance: $3.29


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.24 between high and low, or 7.82%. For the last week, the stock has had a daily average volatility of 6.24%.

Aduro Biotech is oversold on RSI14 (26). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

6.24 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Aduro Biotech holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Strong Sell Candidate Downgraded
Stronger Sell Today ADRO ranks #5471 as SELL CANDIDATE #5471 Weaker Sell
ADRO $3.14 ($-0.12 -3.68%)
ADRO is down $0.12 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for ADRO based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the ADRO analysis is free »

Will ADRO stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank